Presentation TCT 2016 TCT 400: The Importance of Implantation Technique in Ensuring Optimal Outcomes After Bioresorbable Scaffold Implantation: Implications From a Real-World Cohort Presenter: Ronald Caputo, Maurizio Menichelli November 01, 2016
Presentation TCT 2016 Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective! Presenter: Jonathan M. Hill, Christoph K. Naber, Joanna J. Wykrzykowska November 01, 2016
Presentation TCT 2016 Can QCA Be Trusted? Insights From OCT and More Presenter: Jonathan M. Hill, Christoph K. Naber, Yoshinobu Onuma November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: PLATINUM DIVERSITY Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner November 01, 2016
Presentation TCT 2016 TCT 399: Impact of Post-Dilatation on Angiographic and Clinical Outcomes of Patients Undergoing Bioresorbable Scaffold Implantation in Clinical Practice Presenter: Ronald Caputo, Maurizio Menichelli November 01, 2016
Presentation TCT 2016 BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA or Intracoronary Imaging (With Case Examples)? Presenter: Jonathan M. Hill, Christoph K. Naber, Alexandre Abizaid November 01, 2016
Presentation TCT 2016 Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With Case Examples) Presenter: Jonathan M. Hill, Christoph K. Naber, Corrado Tamburino November 01, 2016
Presentation TCT 2016 Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS Presenter: Jonathan M. Hill, Christoph K. Naber, Manel Sabate November 01, 2016
Presentation TCT 2016 Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results) Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis November 01, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
Presentation TCT 2016 Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman November 01, 2016
Presentation TCT 2016 Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns November 01, 2016
Presentation TCT 2016 Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel November 01, 2016
Presentation TCT 2016 A Critical Review of Technique Across the Absorb Trials Presenter: Stephen G. Ellis, Patrick W. Serruys November 01, 2016
Presentation TCT 2016 PSP: A Synthesis of Technique Imperatives for Absorb Implantation Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik November 01, 2016
Presentation TCT 2016 Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement Presenter: Michael C. John, Gregg W. Stone, Jason R. Weidman November 01, 2016
Presentation TCT 2016 Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis November 01, 2016
Presentation TCT 2016 Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch Presenter: Stephen G. Ellis, Patrick W. Serruys November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding November 01, 2016